Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4⁺ immune responses

Area of Science:

• Immunology
• Virology
• Post-COVID Conditions

Background:

• Post-acute sequelae of COVID-19 (PASC) affect multiple organ systems.
• The exact causes of PASC are unknown, with theories including viral persistence, immune activation, and autoimmunity.
• Understanding PASC pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

• To investigate T cell memory responses in PASC patients one year after hospital discharge.
• To correlate T cell responses with clinical parameters in PASC.
• To identify a potential immune fingerprint associated with PASC.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) from PASC patients and healthy controls were stimulated with SARS-CoV-2 spike peptides.
• CD4+ and CD8+ T cell responses were quantified using flow cytometry and the activation-induced markers (AIM) assay.
• Clinical data, including lung function (DLCO) and residual symptoms, were collected.

Main Results:

• PASC patients exhibited significantly higher CD4+ T cell activation compared to healthy controls.
• Central memory (CM) T cells expressing pro-inflammatory cytokines were more common in PASC responders.
• Elevated SARS-CoV-2-specific T cell responses correlated with reduced DLCO and persistent symptoms.

Conclusions:

• Immune system alterations, particularly within CM T cells, are implicated in PASC development and persistence.
• These T cell changes may significantly impact the quality of life for individuals with PASC.
• Further research into T cell dynamics could reveal therapeutic targets for PASC.